| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |